Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 2/20 | 0.43 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.43 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | PNMT | P11086 | 1/20 | 0.42 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.38 |
| ▸ | IDO1 | P14902 | 2/20 | 0.38 |
| ▸ | TDO2 | P48775 | 2/20 | 0.38 |
| ▸ | IDO2 | Q6ZQW0 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12744755 | 0.86 | ADRB2 (0.46) | ADRB2ADRB1AOC3CYP3A4CYP2D6 | |
| SCHEMBL19121577 | 0.86 | ADRB2 (0.46) | ADRB2ADRB1AOC3CYP3A4CYP2D6 | |
| SCHEMBL19574904 | 0.86 | ADRB2 (0.46) | ADRB2ADRB1AOC3CYP3A4CYP2D6 | |
| SCHEMBL9908235 | 0.86 | ADRB2 (0.46) | ADRB2ADRB1AOC3CYP3A4CYP2D6 | |
| SCHEMBL22911512 | 0.77 | ADRB2 (0.43) | ADRB2ADRB1AOC3CYP3A4CYP2D6 | |
| SCHEMBL9746507 | 0.77 | ADRB2 (0.43) | ADRB2ADRB1AOC3CYP3A4CYP2D6 | |
| SCHEMBL24725717 | 0.76 | ADRB2 (0.46) | ADRB2ADRB1AOC3CYP3A4CYP2D6 | |
| SCHEMBL320794 | 0.76 | P2RX7 (0.47) | ADRB2ADRB1AOC3CYP3A4CYP2D6 | |
| SCHEMBL13145151 | 0.76 | P2RX7 (0.47) | ADRB2ADRB1AOC3CYP3A4CYP2D6 | |
| SCHEMBL17069234 | 0.76 | TSHR (0.50) | ADRB2ADRB1AOC3CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10525030-B2 | Phenyl carbamate compound and a composition for neuroprotection comprising the same | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2020-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10525030-B2 | Phenyl carbamate compound and a composition for neuroprotection comprising the same | CHAT, BAX, CASP3 | ADRB2 3595/4885ADRB1 2777/4885AOC3 887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.